十一月 2025
- Home
- Genomind
十一月 2025的Genomind市场份额分析
Your Medication Management Partner Unlocking better outcomes through precision health technology. View Solutions Evolving how we prescribe medicine Our understanding of genetics is changing how we prescribe. As the science of medicine evolves, we feel a responsibility to deliver solutions that keep pace with that change.Our innovative, precision health technology can unlock the ability to
Genomind(包含公司地区分支机构)
查看更多网站流量和参与度信息- genomind.com
Genomind收入截至 十一月 2025为 25M - 50M
Genomind主要域名产生的收入
3 年中Genomind主要域名的收入
Genomind主要域名的收入
Genomind热门域名的总访问量
了解Genomind市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
Genomind热门域名的平均访问时长
分析Genomind参与度指标。
过去 3 个月的平均访问时长
子公司明细
Genomind热门域名的平均页面浏览量
了解Genomind如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Genomind 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Genomind, Inc. partners with Shore Quality Partners CIN.Genomind, a provider of population health management solutions and genetic testing for medication management, has partnered with Shore Quality Partners (SQP), an Accountable Care Organization (ACO) serving 28,000 Medicaid members of Somers Point, NJ and surrounding communities.
十二月 1, 2022阅读更多
新闻Genomind, Inc. partners with Parkview Regional Medical Center.Genomind, a provider of genetic testing and population health management solutions for medication management, has partnered with Parkview Physicians Group – Psychiatry in Fort Wayne, Indiana, to complete an interface for laboratory orders and results with Parkview’s Epic electronic health record (EHR) system.
八月 8, 2022阅读更多
新闻Genomind, Inc. hires David Nash as member of Scientific Advisory Board.Genomind®, a leading precision healthcare company, has named David Nash, MD, MBA the newest member of its Scientific Advisory Board (SAB).
十一月 9, 2021阅读更多
查看 Genomind 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。